Target Receptor Identification and Subsequent Treatment of Resected Brain Tumors with Encapsulated and Engineered Allogeneic Stem Cells

Scientists showed the detection of cell surface death receptor target on CD146-enriched circulating tumor cells captured from the blood of mice bearing glioblastoma (GBM) and patients diagnosed with GBM.